Publicacions en què col·labora amb ÁNGEL PÉREZ NÚÑEZ (8)

2019

  1. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab

    Clinical and Translational Oncology, Vol. 21, Núm. 10, pp. 1413-1423

  2. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival

    Neurocirugia, Vol. 30, Núm. 1, pp. 11-18

2018

  1. Tumor cell vanishing with radiological changes suggesting progression in IDH-mutated diffuse astrocytoma treated only with surgery

    Clinical Neuropathology, Vol. 37, Núm. 5, pp. 217-220

2017

  1. Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab

    Clinical and Translational Oncology, Vol. 19, Núm. 1, pp. 51-57

2016

  1. Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma

    Neurology

2014

  1. A prognostic model based on preoperative MRI predicts overall survival in patients with diffuse gliomas

    American Journal of Neuroradiology, Vol. 35, Núm. 6, pp. 1096-1102

2013

  1. Brainstem Gliomas

    Seminars in Ultrasound, CT and MRI, Vol. 34, Núm. 2, pp. 104-112

2012

  1. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas

    American Journal of Neuroradiology, Vol. 33, Núm. 4, pp. 701-707